Blood Based Biomarkers as Predictive Factors for Hyperprogressive Disease

Purpose: With the widespread use of immunotherapy agents, we encounter treatment responses such as hyperprogression disease (HPD) that we have not seen with previous standard chemotherapy and targeted therapies. It is known that survival in patients with HPD is shorter than in patients without HPD....

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of clinical medicine 2022-09, Vol.11 (17), p.5171
Hauptverfasser:	Yildirim, Hasan Cagri, Guven, Deniz Can, Aktepe, Oktay Halit, Taban, Hakan, Yilmaz, Feride, Yasar, Serkan, Aksoy, Sercan, Erman, Mustafa, Kilickap, Saadettin, Yalcin, Suayib
Format:	Artikel
Sprache:	eng
Schlagworte:	Immunotherapy Kidney cancer Medical prognosis Melanoma Metastasis Neutrophils Patients Regression analysis Skin cancer Survival analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!